These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1980590)

  • 21. [The tumor markers CEA and CA-19.9 in patients with colorectal carcinoma].
    Ralchev K; Dudunkov Z; Dimitrov V; Stancheva Iu; Tsingilev D
    Khirurgiia (Sofiia); 1991; 44(1):53-7. PubMed ID: 1942906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The optimization of the detection of tumors of the organs of the hepatobiliopancreatic area by a combination of the ultrasonic study method and of the determination of tumor markers in the blood serum].
    Mit'kov VV; Briukhovetskiĭ IuA
    Ter Arkh; 1992; 64(4):86-9. PubMed ID: 1440318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen.
    Novell F; Trias M; Molina R; Filella X
    Anticancer Res; 1997; 17(4A):2743-6. PubMed ID: 9252708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.
    He WZ; Guo GF; Yin CX; Jiang C; Wang F; Qiu HJ; Chen XX; Rong RM; Zhang B; Xia LP
    Colorectal Dis; 2013 Aug; 15(8):e443-52. PubMed ID: 23621885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
    Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low preoperative serum carcinoembryonic antigen concentration is a marker of good prognosis in patients undergoing cryotherapy for low volume hepatic metastases from colorectal cancer.
    Seifert JK; Morris DL
    Int J Surg Investig; 2000; 2(4):327-34. PubMed ID: 12678536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen concentration: a prospective study.
    Tuech JJ; Pessaux P; Regenet N; Daver A; Lorimier G; Bergamaschi R; Arnaud JP
    J Surg Oncol; 2004 Oct; 88(1):27-31. PubMed ID: 15384059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of phosphohexose isomerase as a metastasis marker in breast cancer patients.
    Yasasever V; Dinçer M; Camlica H; Duranyildiz D; Dalay N
    Eur J Gynaecol Oncol; 1997; 18(5):397-9. PubMed ID: 9378161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection.
    Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E
    J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncologic markers in patients with colorectal cancer after a complex therapy.
    Vyslouzil K; Klementa I; Stary L; Duda M; Skalicky P; Kapustova M; Dlouhy M; Benes P
    Bratisl Lek Listy; 2004; 105(10-11):389-91. PubMed ID: 15658583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen.
    Huber K; Kirchheimer JC; Sedlmayer A; Bell C; Ermler D; Binder BR
    Cancer Res; 1993 Apr; 53(8):1788-93. PubMed ID: 8467497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detecting curable disease following hepatectomy for colorectal metastases.
    Metcalfe M; Mann C; Mullin E; Maddern G
    ANZ J Surg; 2005 Jul; 75(7):524-7. PubMed ID: 15972037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.
    Anannamcharoen S; Boonya-Ussadol C
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificity of tumor markers (CEA, GICA, TPA, alpha-FP, FpA, gamma-GT) for the diagnosis of hepatic metastases from large bowel cancers.
    Abbasciano V; Levato F; Zavagli G
    Med Oncol Tumor Pharmacother; 1989; 6(2):129-32. PubMed ID: 2473362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
    Veingerl B
    Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of measuring liver volume for detecting occult hepatic metastases from colorectal or gastric cancer.
    Ishizawa T; Yamamoto T; Nishida K; Tsukui H; Sekikawa T
    World J Surg; 2005 Jun; 29(6):719-22. PubMed ID: 15895192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour markers and radiological examinations in the follow-up of patients with oral cancer.
    Söderholm AL; Lindqvist C; Haglund C
    J Craniomaxillofac Surg; 1992 Jul; 20(5):211-5. PubMed ID: 1357004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biliary carcinoembryonic antigen in the diagnosis of occult hepatic metastases from colorectal cancer.
    Li Destri G; Curreri R; Lanteri R; Gagliano G; Rodolico M; Di Cataldo A; Puleo S
    J Surg Oncol; 2002 Sep; 81(1):8-11. PubMed ID: 12210019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microinvasion of liver metastases from colorectal cancer: predictive factors and application for determining clinical target volume.
    Qian Y; Zeng ZC; Ji Y; Xiao YP
    Radiat Oncol; 2015 Jun; 10():125. PubMed ID: 26040515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Arginase as a marker of cancerogenesis. III. Comparison of arginase activity with CEA and Ca 19-9 in liver metastases of colorectal cancer].
    Porembska Z; Skwarek A; Chrzanowska A; Mielczarek M; Nyckowski P; Barańczyk-Kuźma A
    Pol Merkur Lekarski; 2004 Jan; 16(91):31-3. PubMed ID: 15074017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.